REPORT ID 4197

EMEA (Europe, Middle East and Africa) Follicle-stimulating Hormone (FSH) Market Report 2019

Publish Date
2019
Pages
102
Format
Electronic (PDF)

In this report, the EMEA Follicle-stimulating Hormone (FSH) market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Doses), revenue (Million USD), market share and growth rate of Follicle-stimulating Hormone (FSH) for these regions, from   2019 to 2025 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Follicle-stimulating Hormone (FSH) market competition by top manufacturers/players, with Follicle-stimulating Hormone (FSH) sales volume (K Doses), price (USD/Dose), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Merck Serono
    MSD
    IBSA
    Ferring
    Livzon
    Techwell
    GenSci
    ...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Recombinant FSH
    Urinary FSH

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Infertility Treatment
    Assisted Reproductive Technology

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Follicle-stimulating Hormone (FSH) Market  Report 2019
1 Follicle-stimulating Hormone (FSH) Overview
    1.1 Product Overview and Scope of Follicle-stimulating Hormone (FSH)
    1.2 Classification of Follicle-stimulating Hormone (FSH)
        1.2.1 EMEA Follicle-stimulating Hormone (FSH) Market Size (Sales) Comparison by Type ( 2014-2024)
        1.2.2 EMEA Follicle-stimulating Hormone (FSH) Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 Recombinant FSH
        1.2.4 Urinary FSH
    1.3 EMEA Follicle-stimulating Hormone (FSH) Market by Application/End Users
        1.3.1 EMEA Follicle-stimulating Hormone (FSH) Sales (Volume) and Market Share Comparison by Application ( 2014-2024
        1.3.2 Infertility Treatment
        1.3.3 Assisted Reproductive Technology
    1.4 EMEA Follicle-stimulating Hormone (FSH) Market by Region
        1.4.1 EMEA Follicle-stimulating Hormone (FSH) Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 Europe Status and Prospect ( 2014-2024)
        1.4.3 Middle East Status and Prospect ( 2014-2024)
        1.4.4 Africa Status and Prospect ( 2014-2024)
    1.5 EMEA Market Size (Value and Volume) of Follicle-stimulating Hormone (FSH) ( 2014-2024)
        1.5.1 EMEA Follicle-stimulating Hormone (FSH) Sales and Growth Rate ( 2014-2024)
        1.5.2 EMEA Follicle-stimulating Hormone (FSH) Revenue and Growth Rate ( 2014-2024)

2 EMEA Follicle-stimulating Hormone (FSH) Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Follicle-stimulating Hormone (FSH) Market Competition by Players/Manufacturers
        2.1.1 EMEA Follicle-stimulating Hormone (FSH) Sales Volume and Market Share of Major Players ( 2014-2019)
        2.1.2 EMEA Follicle-stimulating Hormone (FSH) Revenue and Share by Players ( 2014-2019)
        2.1.3 EMEA Follicle-stimulating Hormone (FSH) Sale Price by Players ( 2014-2019)
    2.2 EMEA Follicle-stimulating Hormone (FSH) (Volume and Value) by Type/Product Category
        2.2.1 EMEA Follicle-stimulating Hormone (FSH) Sales and Market Share by Type ( 2014-2019)
        2.2.2 EMEA Follicle-stimulating Hormone (FSH) Revenue and Market Share by Type ( 2014-2019)
        2.2.3 EMEA Follicle-stimulating Hormone (FSH) Sale Price by Type ( 2014-2019)
    2.3 EMEA Follicle-stimulating Hormone (FSH) (Volume) by Application
    2.4 EMEA Follicle-stimulating Hormone (FSH) (Volume and Value) by Region
        2.4.1 EMEA Follicle-stimulating Hormone (FSH) Sales and Market Share by Region ( 2014-2019)
        2.4.2 EMEA Follicle-stimulating Hormone (FSH) Revenue and Market Share by Region ( 2014-2019)
        2.4.3 EMEA Follicle-stimulating Hormone (FSH) Sales Price by Region ( 2014-2019)

3 Europe Follicle-stimulating Hormone (FSH) (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Follicle-stimulating Hormone (FSH) Sales and Value ( 2014-2019)
        3.1.1 Europe Follicle-stimulating Hormone (FSH) Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 Europe Follicle-stimulating Hormone (FSH) Revenue and Growth Rate ( 2014-2019)
    3.2 Europe Follicle-stimulating Hormone (FSH) Sales and Market Share by Type
    3.3 Europe Follicle-stimulating Hormone (FSH) Sales and Market Share by Application
    3.4 Europe Follicle-stimulating Hormone (FSH) Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Follicle-stimulating Hormone (FSH) Sales Volume by Countries ( 2014-2019)
        3.4.2 Europe Follicle-stimulating Hormone (FSH) Revenue by Countries ( 2014-2019)
        3.4.3 Germany Follicle-stimulating Hormone (FSH) Sales and Growth Rate ( 2014-2019)
        3.4.4 France Follicle-stimulating Hormone (FSH) Sales and Growth Rate ( 2014-2019)
        3.4.5 UK Follicle-stimulating Hormone (FSH) Sales and Growth Rate ( 2014-2019)
        3.4.6 Russia Follicle-stimulating Hormone (FSH) Sales and Growth Rate ( 2014-2019)
        3.4.7 Italy Follicle-stimulating Hormone (FSH) Sales and Growth Rate ( 2014-2019)
        3.4.8 Benelux Follicle-stimulating Hormone (FSH) Sales and Growth Rate ( 2014-2019)

4 Middle East Follicle-stimulating Hormone (FSH) (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Follicle-stimulating Hormone (FSH) Sales and Value ( 2014-2019)
        4.1.1 Middle East Follicle-stimulating Hormone (FSH) Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Middle East Follicle-stimulating Hormone (FSH) Revenue and Growth Rate ( 2014-2019)
    4.2 Middle East Follicle-stimulating Hormone (FSH) Sales and Market Share by Type
    4.3 Middle East Follicle-stimulating Hormone (FSH) Sales and Market Share by Application
    4.4 Middle East Follicle-stimulating Hormone (FSH) Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Follicle-stimulating Hormone (FSH) Sales Volume by Countries ( 2014-2019)
        4.4.2 Middle East Follicle-stimulating Hormone (FSH) Revenue by Countries ( 2014-2019)
        4.4.3 Saudi Arabia Follicle-stimulating Hormone (FSH) Sales and Growth Rate ( 2014-2019)
        4.4.4 Israel Follicle-stimulating Hormone (FSH) Sales and Growth Rate ( 2014-2019)
        4.4.5 UAE Follicle-stimulating Hormone (FSH) Sales and Growth Rate ( 2014-2019)
        4.4.6 Iran Follicle-stimulating Hormone (FSH) Sales and Growth Rate ( 2014-2019)

5 Africa Follicle-stimulating Hormone (FSH) (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Follicle-stimulating Hormone (FSH) Sales and Value ( 2014-2019)
        5.1.1 Africa Follicle-stimulating Hormone (FSH) Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 Africa Follicle-stimulating Hormone (FSH) Revenue and Growth Rate ( 2014-2019)
    5.2 Africa Follicle-stimulating Hormone (FSH) Sales and Market Share by Type
    5.3 Africa Follicle-stimulating Hormone (FSH) Sales and Market Share by Application
    5.4 Africa Follicle-stimulating Hormone (FSH) Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Follicle-stimulating Hormone (FSH) Sales Volume by Countries ( 2014-2019)
        5.4.2 Africa Follicle-stimulating Hormone (FSH) Revenue by Countries ( 2014-2019)
        5.4.3 South Africa Follicle-stimulating Hormone (FSH) Sales and Growth Rate ( 2014-2019)
        5.4.4 Nigeria Follicle-stimulating Hormone (FSH) Sales and Growth Rate ( 2014-2019)
        5.4.5 Egypt Follicle-stimulating Hormone (FSH) Sales and Growth Rate ( 2014-2019)
        5.4.6 Algeria Follicle-stimulating Hormone (FSH) Sales and Growth Rate ( 2014-2019)

6 EMEA Follicle-stimulating Hormone (FSH) Manufacturers/Players Profiles and Sales Data
    6.1 Merck Serono
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Follicle-stimulating Hormone (FSH) Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Merck Serono Follicle-stimulating Hormone (FSH) Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 MSD
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Follicle-stimulating Hormone (FSH) Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 MSD Follicle-stimulating Hormone (FSH) Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 IBSA
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Follicle-stimulating Hormone (FSH) Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 IBSA Follicle-stimulating Hormone (FSH) Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 Ferring
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Follicle-stimulating Hormone (FSH) Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Ferring Follicle-stimulating Hormone (FSH) Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 Livzon
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Follicle-stimulating Hormone (FSH) Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Livzon Follicle-stimulating Hormone (FSH) Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 Techwell
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Follicle-stimulating Hormone (FSH) Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Techwell Follicle-stimulating Hormone (FSH) Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 GenSci
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Follicle-stimulating Hormone (FSH) Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 GenSci Follicle-stimulating Hormone (FSH) Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    ...

7 Follicle-stimulating Hormone (FSH) Manufacturing Cost Analysis
    7.1 Follicle-stimulating Hormone (FSH) Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Follicle-stimulating Hormone (FSH)

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Follicle-stimulating Hormone (FSH) Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Follicle-stimulating Hormone (FSH) Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Follicle-stimulating Hormone (FSH) Market Forecast ( 2019-2025)
    11.1 EMEA Follicle-stimulating Hormone (FSH) Sales, Revenue and Price Forecast ( 2019-2025)
        11.1.1 EMEA Follicle-stimulating Hormone (FSH) Sales and Growth Rate Forecast ( 2019-2025)
        11.1.2 EMEA Follicle-stimulating Hormone (FSH) Revenue and Growth Rate Forecast ( 2019-2025)
        11.1.3 EMEA Follicle-stimulating Hormone (FSH) Price and Trend Forecast ( 2019-2025)
    11.2 EMEA Follicle-stimulating Hormone (FSH) Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.3 Europe Follicle-stimulating Hormone (FSH) Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.4 Middle Eastt Follicle-stimulating Hormone (FSH) Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.5 Africa Follicle-stimulating Hormone (FSH) Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.6 EMEA Follicle-stimulating Hormone (FSH) Sales Forecast by Type ( 2019-2025)
    11.7 EMEA Follicle-stimulating Hormone (FSH) Sales Forecast by Application ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer